68.5 F
Hobe Sound
Thursday, September 20, 2018
Complimentary

Specialists

Complimentary

Industry

ADVERTISE

In the Spotlight

Medical device news includes clinical trial updates, product launches, profiles of device companies, acquisitions, executives on the move and more which is of great interest to the practicing medical specialist, industry executive, investor and other allied health professional. The publication also reports non-profit related news and more. We invite you to visit our magazine daily!

BREAKING MEDICAL DEVICE NEWS

First Commercial Launch of Peripheral Orbital Atherectomy System Outside the United States Reports Cardiovascular Systems

9/19/18: Dr. Bryan Yan, Associate Professor, Chinese University of Hong Kong, who treated the first patient in Hong Kong, said, “Patients with severely calcified peripheral arteries can be difficult to treat due to the limitations of traditional angioplasty or stenting. This can also place patients at risk for subsequent complications including repeat interventions and amputation. The commercialization of the Stealth 360® OAS in Hong Kong provides physicians with a minimally invasive treatment option for this complex patient population. I am very satisfied with the procedural outcome for my patient because I was able to avoid implanting a stent in the distal superficial femoral artery and I look forward to continuing treatment of similar patients with this technology.”

CARILLON Pivotal Trial Update: First Patient Randomized

9/19/18: “Current treatments to improve the quality of life for patients with FMR fall short and many heart failure patients are too frail for open-heart surgery,” said Samir Kapadia, M.D., interventional cardiologist and Cath Lab director at the Heart & Vascular Institute, Cleveland Clinic, and one of the principal investigators of the CARILLON Pivotal Trial.

Cepheid Receives CE-IVD clearance for Xpert HCV VL Fingerstick

9/19/18: Currently, the clinical care pathway for detection of hepatitis C faces many barriers, including complicated multi-step diagnostic algorithms based on antibody screening and RNA confirmation

Occlusin® 500 Embolization Microspheres in Benign Prostatic Hypertrophy Patients to be presented at the 2018 Cardiovascular and Interventional Radiological Society of Europe Annual Meeting

9/19/18: Dr. Richard Owen, lead investigator of the clinical study conducted at the University of Alberta Hospital, will be the presenter.
9/19/18: Unlike most traditional full face mask cushions, AirFit F30’s sits below the nasal bridge, preventing top-of-the-nose red marks and irritation, and reducing feelings of claustrophobia for some full face wearers.

MIACH Orthopaedics Secures $22.5 Million Series A Financing

9/17/18: “We believe that BEAR technology has the potential to transform connective tissue repair, and we’re gratified that Amzak, DSM and the NFL Players Association share our vision to explore its application in ACL repair,” said Martha Murray, M.D., founder of MIACH Orthopaedics, professor of orthopaedic surgery at Harvard Medical School and a practicing orthopaedic surgeon in the Sports Medicine Division at Boston Children’s Hospital. “We look forward to accelerating clinical trials to further evaluate the less-invasive BEAR technology as a viable alternative to ACL reconstruction.”

W.L. Gore & Associates Reports First Patient in Europe Receives Implant of GORE® EXCLUDER® Conformable AAA Endoprosthesis with ACTIVE CONTROL System and Enrolls in...

9/17/18: “Before this device, EVAR was reserved for patients whose aorta fell within a standard shape and size,” said Prof. van Sambeek. “The conformability of the new GORE EXCLUDER Conformable Device in combination with the angulation control of the new delivery system will allow us to offer a less invasive, lower-risk alternative to open surgery to more AAA patients than ever before. The EXCeL registry will track the real-world effectiveness and safety of the device, and I look forward to enrolling additional patients with challenging, highly angulated aortic anatomies and seeing the long-term value of this device.”

Market Reports

Patient Temperature Monitoring Market Global Forecast to 2023

9/19/18: The global patient temperature monitoring market is projected to reach USD 3.21 billion by 2023 from USD 2.55 billion in 2018, at a CAGR of 4.7%.

The Global Medical Gas Analyzers Market 2018-2025: A $325 Million Opportunity

9/18/18: The medical gas analyzers market is anticipated to show significant growth during the forecast period, due to upsurge in adoption of medical gas analyzers, stringent regulation for medical gas system, and increase in demand for advanced medical gas analyzing systems.

Structural Heart Devices Market Global Forecast to 2023

9/13/18: By product, occluders and delivery systems, annuloplasty rings, and accessories p;us procedure.

Executives

9/19/18: “Cell Microsystems has established a pipeline of products including the AIR System for the automated isolation and recovery of single cells as well as next generation platforms,” said Gary Pace, CEO. “With this momentum we are now well positioned to expand our commercial opportunities and James is the perfect addition to the team to make that happen.”
9/14/18: “I’ve worked closely with Dr. Shuren for years,” said Senator Orrin Hatch, who has been a champion for the life sciences industry in the Senate. “We’re excited to have Dr. Shuren come to our state and get to know the wide range of innovation taking place here - from promising startups to large, established companies. I’m proud of the difference we’re making in patients’ lives.”

SPONSORS